Search

Your search keyword '"Kato, Taku"' showing total 621 results
Start Over Author "Kato, Taku"
621 results on '"Kato, Taku"'

53. Comparison of Aortobifemoral Bypass and Endovascular Treatment for Chronic Infrarenal Abdominal Aortic Occlusion From the CHAOS (CHronic Abdominal Aortic Occlusion, ASian Multicenter) Registry

Author

Fujimura, Naoki, Takahara, Mitsuyoshi, Obara, Hideaki, Ichihashi, Shigeo, George, Robbie K., Igari, Kimihiro, Banno, Hiroshi, Hozawa, Koji, Yamaoka, Terutoshi, Kian, Ch’ng J., Tan, Jimmy W. H., Park, Kihyuk, Skyi, Pang Y. C., Kato, Taku, and Kawarada, Osami

Abstract

Purpose: To directly compare the clinical outcomes of aortobifemoral bypass surgery (ABF) and endovascular treatment (EVT) for chronic total occlusion (CTO) of the infrarenal abdominal aorta (IAA).Materials and Methods: In this retrospective, multicenter study, we used an international database of 436 patients who underwent revascularization for CTO of the IAA between 2007 and 2017 at 30 Asian cardiovascular centers. After excluding 52 patients who underwent axillobifemoral bypass surgery, 384 patients (139 ABFs and 245 EVTs) were included in the analysis. Propensity score-matched analysis was performed to compare clinical results in the periprocedural period and the long-term.Results: Propensity score matching extracted 88 pairs. Procedure time (ABF; 288 [240–345] minutes vs EVT; 159 [100–205] minutes, p<0.001) and length of hospital stay (17 [12–23] days vs 5 [4–13] days, p<0.001) were significantly shorter in the EVT group than in the ABF group, while the proportions of procedural success (98.9% versus 96.6%, p=0.620), complications (9.1% versus 12.3%, p=0.550), and mortality (2.3% versus 3.8%, p=1.000) were not different between the groups. At 1 months, ABI significantly increased more in the ABF group for both in a limb with the lower (0.56 versus 0.50, p=0.018) and the higher (0.49 versus 0.34, p=0.001) baseline ABI, while the change of the Rutherford category was not significantly different between the groups (p=0.590). At 5 years, compared with the EVT group, the ABF group had significantly better primary patency (89.4±4.3% versus 74.8±4.3%, p=0.035) and survival rates (86.9±4.5% versus 66.2±7.5%, p=0.007). However, there was no significant difference between the groups for secondary patency (100.0%±0.0% versus 93.5%±3.9%, p=0.160) and freedom from target lesion revascularization (TLR) (89.3±4.3% vs 77.3±7.3%, p=0.096).Conclusion: Even with recent advancements in EVT, primary patency was still significantly better for ABF in CTO of the IAA. However, there was no difference between the groups in terms of secondary patency and freedom from TLR at 5 years. Furthermore, there was no difference in procedural success, complications, mortality, and improvement in the Rutherford classification during the periprocedural period, with significantly shorter procedure time and hospital stay in the EVT group.

Published
2023
Full Text
View/download PDF

56. Cytomorphology and Gene Expression Signatures of Anchorage-independent Aggregations of Oral Cancer Cells

Author

SAKURAI, KOUHEI, primary, NAGAI, AKIRA, additional, ANDO, TATSUYA, additional, SAKAI, YASUHIRO, additional, IDETA, YUKA, additional, HAYASHI, YUICHIRO, additional, BABA, JUNICHI, additional, MITSUDO, KENJI, additional, AKITA, MASAHARU, additional, YAMAMICHI, NOBUTAKE, additional, FUJIGAKI, HIDETSUGU, additional, KATO, TAKU, additional, and ITO, HIROYASU, additional

Published
2022
Full Text
View/download PDF

57. A deep placement of lime nitrogen reduces the nitrate leaching and promotes soybean growth and seed yield

Author

Ohyama, Takuji, primary, Ikebe, Keisuke, additional, Okuoka, Sotaro, additional, Ozawa, Tomoya, additional, Nishiura, Takuya, additional, Ishiwata, Taiga, additional, Yamazaki, Ayane, additional, Tanaka, Fumu, additional, Takahashi, Toru, additional, Umezawa, Takumi, additional, Ohshima, Hiroyuki, additional, Kato, Taku, additional, Maeda, Yoshiyuki, additional, Saito, Akihiro, additional, Higuchi, Kyoko, additional, Ohtake, Norikuni, additional, Takahashi, Yoshihiko, additional, Harada, Naoki, additional, and Ohkama-Ohtsu, Naoko, additional

Published
2022
Full Text
View/download PDF

59. Impact of Antimicrobial-Resistant Bacterial and Polymicrobial Infection on Wound Healing After Minor Forefoot Amputation in Chronic Limb-Threatening Ischemia With Infection

Author

Kato, Taku, primary, Yanagiuchi, Takashi, additional, Hirano, Keita, additional, Imura, Haruki, additional, Matsubara, Kunihiko, additional, Hanabusa, Katsuyuki, additional, Ota, Yutaro, additional, Yamazaki, Shinya, additional, Ushimaru, Shunpei, additional, and Yokoi, Hirokazu, additional

Published
2022
Full Text
View/download PDF

62. Occurrence of infection following prostate biopsy procedures in Japan: Japanese Research Group for Urinary Tract Infection (JRGU) – A multi-center retrospective study

Author

Togo, Yoshikazu, Kubo, Tatsuhiko, Taoka, Rikiya, Hiyama, Yoshiki, Uehara, Teruhisa, Hashimoto, Jiroh, Kurimura, Yuichiro, Takahashi, Satoshi, Tsukamoto, Taiji, Miyazaki, Jun, Nishiyama, Hiroyuki, Kira, Shinichiro, Kiyota, Hiroshi, Yazawa, Satoshi, Niwa, Naoya, Hongo, Hiroshi, Oya, Mototsugu, Kato, Taku, Yasuda, Mitsuru, Deguchi, Takashi, Ishikawa, Kiyohito, Hoshinaga, Kiyotaka, Matsumoto, Minori, Shigemura, Katsumi, Tanaka, Kazushi, Arakawa, Soichi, Fujisawa, Masato, Wada, Koichiro, Uehara, Shinya, Watanabe, Toyohiko, Kumon, Hiromi, Kobayashi, Kanao, Matsubara, Akio, Matsumoto, Masahiro, Sho, Takehiko, Hamasuna, Ryoichi, Matsumoto, Tetsuro, Hayami, Hiroshi, Nakagawa, Masayuki, and Yamamoto, Shingo

Published
2014
Full Text
View/download PDF

70. Studies on the Genetic Characteristics of the Brewing Yeasts Saccharomyces: A Review.

Author

Kato, Taku and Takahashi, Tomoko

Subjects
BEER flavor & odor, BEER industry, BEER brewing, LAGER beer, SACCHAROMYCES, SACCHAROMYCES cerevisiae, YEAST
Abstract

Brewing yeasts have an essential role in beer production as they convert sugar into ethanol and carbon dioxide and impart flavor to beer during brewing. Brewing yeasts can be classified into the following two types: ale yeast (or top-fermenting yeast; Saccharomyces cerevisiae), which is used for ale-type beer production; lager yeast (or bottom-fermenting yeast; Saccharomyces pastorianus), which is used for lager-type beer production. Globally, approximately 90% of beer is produced using lager yeast. The entire genomes of S. cerevisiae S288C and S. pastorianus Weihenstephan 34/70 were sequenced in 1996 and 2009, respectively. Saccharomyces eubayanus, a parent strain of the lager yeast, was discovered in 2011. These advances have markedly contributed to the studies on brewing characteristics and brewing yeast genes and the rapid development of the field of yeast genetics. To contribute to the development of the beer industry, this review summarizes the genetics of brewer's yeast with a special focus on its genomic structure and the genes involved in brewing characteristics. [ABSTRACT FROM AUTHOR]

Published
2023
Full Text
View/download PDF

72. Predictors of delayed wound healing after simultaneous endovascular treatment and minor forefoot amputation for chronic limb-threatening ischemia with wound infection

Author

Yanagiuchi, Takashi, primary, Kato, Taku, additional, Hirano, Keita, additional, Toki, Hiroyuki, additional, Imura, Haruki, additional, Matsubara, Kunihiko, additional, Ushimaru, Shunpei, additional, Yokoi, Hirokazu, additional, Zen, Kan, additional, and Matoba, Satoaki, additional

Published
2022
Full Text
View/download PDF

73. 異時性に同部位の恥骨転移を来たした前立腺癌・上行結腸癌による同時性重複癌の1例

Author

Ito, Hiroki, Hishida, Seiji, Taniguchi, Tomoki, Kato, Daiki, Takai, Manabu, Iinuma, Koji, Muramatsu-Maekawa, Yuka, Kato, Taku, Nakane, Keita, Mizutani, Kosuke, Tsuchiya, Tomohiro, Takahashi, Takao, Suzui, Natuko, Miyazaki, Tatsuhiko, and Koie, Takuya

Subjects
Prostate cancer, Ascending colon cancer, 494.9, Double cancer, digestive system diseases, Metachronous pubic bone metastases
Abstract

A 70-year-old man visited a private hospital with the chief complaint of right lower limb pain. Fluorodeoxyglucose-emission tomography (FDG-PET) showed abnormal uptake in the pubic bone, right femur, and ascending colon. The patient was referred to our hospital for further evaluation. The following tumor marker levels were found : prostate-specific antigen (PSA) 20.57 ng/ml, carcinoembryonic antigen (CEA) 108.5 ng/ml, carbohydrate antigen 19-9 (CA19-9) 1, 002.1 U/ml. An open pubic bone biopsy was performed. The pathological diagnosis was metastatic adenocarcinoma from prostate cancer. Prostate and ascending colon cancers were clinically diagnosed as T2bN0M1b and T2N0M0, respectively. Laparoscopic colectomy was performed. Androgen deprivation therapy started immediately and the serum PSA level was maintained at

Published
2020

74. Retroperitoneal Dedifferentiated Liposarcoma which Could Be Diagnosed Using Dual Color in Situ Hybridization : A Case Report

Author

Iinuma, Koji, Hishida, Seiji, Ito, Hiroki, Taniguchi, Tomoki, Takai, Manabu, Kato, Daiki, Muramatsu (Maekawa), Yuka, Nakane, Keita, Kato, Taku, Mizutani, Kosuke, Tsuchiya, Tomohiro, Higashi, Toshiya, Murase, Katsutoshi, Suzui, Natsuko, Miyazaki, Tatsuhiko, and Koie, Takuya

Subjects
Dedifferentiated liposarcoma, Dual color in situ hybridization, 494.9
Abstract

Ten years ago, a seventy-year-old female underwent extirpation of a left retroperitoneal tumor that was 58×36 mm in size. The pathological diagnosis was malignant peripheral nerve sheath tumor (MPNST) at that time. The patients visited our hospital with the chief complaint of back pain at ten years after surgery. Computer tomography (CT) showed recurrent tumors at the pancreas and the left kidney. Fine-needle aspiration biopsy was performed because of the possibility of pancreatic tumor. The pathological diagnosis was the recurrence of MPNST. The patient underwent extirpation of the recurrent tumors along with the pancreatic body and tail, transverse colon, spleen and left kidney. The definitive diagnosis was dedifferentiated liposarcoma with murine double minute 2 (MDM2) gene amplification and positive of p16Ink4 (p16). The previously resected tumor also revealed MDM2 gene amplification and positive of p16. Based on these results, our diagnosis in this case was recurrence of dedifferentiated liposarcoma. At 6 months after surgery, the patient had no local recurrence or distant metastases.

Published
2020

81. Suppressor effect of catechol-O-methyltransferase gene in prostate cancer

Author

Hashimoto, Yutaka, primary, Shiina, Marisa, additional, Maekawa, Shigekatsu, additional, Kato, Taku, additional, Shahryari, Varahram, additional, Kulkarni, Priyanka, additional, Dasgupta, Pritha, additional, Yamamura, Soichiro, additional, Saini, Sharanjot, additional, Tabatabai, Z. Laura, additional, Dahiya, Rajvir, additional, and Tanaka, Yuichiro, additional

Published
2021
Full Text
View/download PDF

83. A multi‐institutional study of salivary gland cytopathology: Application of the Milan System for Reporting Salivary Gland Cytopathology in Japan

Author

Higuchi, Kayoko, primary, Urano, Makoto, additional, Akiba, Jun, additional, Nogami, Miwako, additional, Hirata, Yukiya, additional, Zukeran, Yoko, additional, Moriyoshi, Koki, additional, Tada, Yuichiro, additional, Fukushima, Mana, additional, Obayashi, Mariko, additional, Sakamoto, Shinnichi, additional, Kuraoka, Kazuya, additional, Kira, Kana, additional, Kawahara, Akihiko, additional, Kato, Taku, additional, Tanigawa, Maki, additional, Nakaguro, Masato, additional, Yamamoto, Hidetaka, additional, and Nagao, Toshitaka, additional

Published
2021
Full Text
View/download PDF

84. New clinical strain of Neisseria gonorrhoeae with decreased susceptibility to ceftriaxone, Japan

Author

Deguchi, Takashi, Yasuda, Mitsuru, Hatazaki, Kyoko, Kameyama, Koji, Horie, Kengo, Kato, Taku, Mizutani, Kohsuke, Seike, Kensaku, Tsuchiya, Tomohiro, Yokoi, Shigeaki, Nakano, Masahiro, and Yoh, Mutsumasa

Subjects
Neisseria gonorrhoeae -- Distribution -- Research, Company distribution practices, Health
Abstract

To the Editor: In 2009, 2010, and 2013, Neisseria gonorrhoeae strains H041 (ceftriaxone MIC of 2 mg/L), F89 (ceftriaxone MIC of 1 mg/L), and A8806 (ceftriaxone MIC of 0.5 mg/L) [...]

Published
2016

85. Cardiac Metastasis in a Patient with Clear Cell Renal Cell Carcinoma who Underwent Multimodality Therapy for Multiple Metastases after Radical Nephrectomy

Author

Takeuchi, Shinichi, Mizutani, Kosuke, Iinuma, Koji, Muramatsu-Maekawa, Yuka, Horie, Kengo, Kato, Taku, Nakane, Keita, Tsuchiya, Tomohiro, Nakano, Masahiro, and Koie, Takuya

Subjects
Clear cell renal cell carcinoma, 494.9, Cardiac metastasis
Abstract

The patient underwent laparoscopic left radical nephrectomy for clear cell renal cell carcinoma (ccRCC). After surgery, the patient had multiple lung metastases and underwent the combination therapy of radiofrequency ablation, interferon-alpha, and inteleukin-2. Thereafter, computed tomography showed multiple lymph node and brain metastases. The patient was administered targeted therapy and radiation. Eventually, the patient suddenly complained of dyspnea. An echocardiogram, coronary angiography and magnetic resonance imaging suggested acute heart failure and pericardial effusion due to a metastatic tumor in the cardiac anteroseptal and posterior wall. Nivolumab was administered for cardiac metastases. The patient has been in stable condition with no progression of cardiac metastases after the administration of nivolumab for 22 months.

Published
2019

92. Proteomic analysis of extracellular vesicles identified PI3K pathway as a potential therapeutic target for cabazitaxel‐resistant prostate cancer

Author

Hishida, Seiji, primary, Kawakami, Kyojiro, additional, Fujita, Yasunori, additional, Kato, Taku, additional, Takai, Manabu, additional, Iinuma, Koji, additional, Nakane, Keita, additional, Tsuchiya, Tomohiro, additional, Koie, Takuya, additional, Miura, Yuri, additional, Ito, Masafumi, additional, and Mizutani, Kosuke, additional

Published
2021
Full Text
View/download PDF

95. Profiling of Serum Extracellular Vesicles Reveals miRNA-4525 as a Potential Biomarker for Advanced Renal Cell Carcinoma

Author

MURAMATSU-MAEKAWA, YUKA, primary, KAWAKAMI, KYOJIRO, additional, FUJITA, YASUNORI, additional, TAKAI, MANABU, additional, KATO, DAIKI, additional, NAKANE, KEITA, additional, KATO, TAKU, additional, TSUCHIYA, TOMOHIRO, additional, KOIE, TAKUYA, additional, MIURA, YURI, additional, ITO, MASAFUMI, additional, and MIZUTANI, KOSUKE, additional

Published
2021
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results